Fatemeh Habibi Nameghi

Ms. Fatemeh Habibi Nameghi

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Open Heart
Verified
Journal Article
Open access
PDF file
MFMarcus Flather
Marcus Flather
FNFatemeh Habibi Nameghi
Fatemeh Habibi Nameghi
A major challenge for clinical health professionals is how best to advise otherwise healthy patients on their long-term cardiovascular disease (CVD) prognosis and make recommendations about the efficacy and safety of CVD prevention therapies.1 CVD risk modelling and therapeutic advice usually relies on a 10-year time horizon which makes it difficult in younger populations where risks appear low and efficacy of preventive therapies is uncertain. However, younger patients without evidence of CVD typically have three or more decades of life expectancy, and therefore understanding longer-term risk patterns and ensuring that CVD outcomes are measured appropriately are key to providing reliable information for patients. Various approaches have been used to try and extrapolate beyond the 10-year time horizon for risk modelling including assuming that event rates are linear or using statistical algorithms to project longer-term event rates, but there is uncertainty around these methods.2 We appraise the current report by van Trier et al which explores the relevance of long-term CVD risk and which types of events are most useful to inform patients in the clinical setting.3

3 February 2026 in Sustainability
Verified
Journal Article
Open access
PDF file
Nishatabbas RehmatullaNishatabbas Rehmatulla
Nishatabbas Rehmatulla
PIPoorvi Iyer
Poorvi Iyer
FNFatemeh Habibi Nameghi
Fatemeh Habibi Nameghi
This paper examines the measures available to improve operational energy efficiency from the perspective of onboard crew, the barriers associated with implementing those measures and how crew behaviour can be nudged using incentives. A total of 25 semi-structured interviews and subsequent surveys with 42 onboard crew were carried out to gather qualitative information on two main domains: operational efficiency and incentive schemes. In-depth thematic analysis of interviews showed the central and recurring themes such as stakeholder hierarchy, autonomy and accountability, temporal restrictions, profitability and type of charter. Due to the heterogeneity in interview responses on the topic of incentives, online surveys were conducted. The findings of the study show that whilst speed reduction was seen as the single most important measure to optimise, it was also the most difficult to implement in practice due to several barriers. These include contractual obligations, a complex web of accountability and perverse incentives to increase speed. Other measures such as trim–draft optimisation and auxiliary engine load optimisation have smaller efficiency gains but were found to have more potential for increasing implementation through behavioural changes and encouraged through incentives. Both monetary and non-monetary incentives were perceived to be important and going beyond the status quo of incentivising captains so that rewards are shared equitably amongst the crew. Whilst not generalisable, preliminary findings suggest that there is room to consider alternatives to the current approaches on incentives, which do not take advantage of the importance of acknowledgment and recognition, as well as fostering positive interpersonal relationships.

20 May 2026 in British Journal of Hospital Medicine
Verified
Journal Article
Open access
SPSamuel Rustem Panday
Samuel Rustem Panday
FNFatemeh Habibi Nameghi
Fatemeh Habibi Nameghi
FGFederico Giacobbe
Federico Giacobbe
MEMehdi Eskandari
Mehdi Eskandari
APAlexandros Papachristidis
Alexandros Papachristidis
MBMax Baghai
Max Baghai
Valvular heart disease (VHD) affects millions worldwide and remains a major cause of morbidity and mortality, placing a substantial and growing burden on healthcare systems. Over the past two decades, transcatheter therapies have emerged to meet this challenge, transforming the management of aortic, mitral, and tricuspid valve disease. Initially developed for inoperable or high-risk surgical patients, procedures such as transcatheter aortic valve implantation (TAVI) and mitral transcatheter edge-to-edge repair (M-TEER) are now routinely offered across a broader risk spectrum. More recently, tricuspid therapies, including tricuspid transcatheter edge-to-edge repair (T-TEER) and transcatheter valve replacement (TTVR), have emerged to address a significant unmet clinical need. With transcatheter interventions becoming more widely available, clinicians across general and acute medical specialities are increasingly likely to encounter patients before and after these procedures. Familiarity with these therapies will support better decision-making and coordinated care. This review summarises the evolution of transcatheter valve therapy, its role alongside surgery, and the evidence supporting its use. Surgery remains the gold standard for younger or low-risk patients, particularly where long-term durability is essential. Transcatheter therapies now offer safe and effective treatment for older patients, including those with frailty or significant comorbidity, supported by landmark trials, which have demonstrated favourable clinical outcomes in carefully selected populations and underpinned guideline endorsement across risk categories. The importance of the multidisciplinary Heart Team is emphasised, ensuring treatment decisions reflect individual anatomy, comorbidity burden, life expectancy, and procedural risk. As device technology, imaging, and procedural expertise continue to advance, the integration of surgical and transcatheter approaches will support more individualised care and broaden access to definitive treatment for patients across the clinical spectrum.

1 September 2025 in Journal of Visualized Surgery
Verified
Journal Article
Open access
PDF file
FNFatemeh Habibi Nameghi
Fatemeh Habibi Nameghi
GAGiuseppe Aresu
Giuseppe Aresu
APAdam Peryt
Adam Peryt
ACAman Coonar
Aman Coonar
Background and Objective: Double sleeve (DS) lobectomy is a specialised lung-sparing operation which can be offered to patients with centrally located tumours, which can avoid pneumonectomy. The technique is historically performed via thoracotomy, but video-assisted thoracic surgery (VATS) and robotic-assisted thoracic surgery (RATS) are gaining traction as minimally invasive alternatives. There are currently no reviews of these techniques. We aim to provide a narrative review of the techniques of DS lobectomy for lung cancer. Methods: We searched MEDLINE and PubMed for the following Medical Subject Headings (MeSH) terms: “sleeve”, “lobectomy OR resection”, “lung OR cancer OR NSCLC OR tumour”, “VATS, RATS, thoracotomy, open OR minimally invasive”, and limited the review to all English language studies published between 1946 and 23rd October 2024 only. Key Content and Findings: In total, our automatic search criteria found 173 papers discussing sleeve lobectomies/resections. After manual sorting, 36 studies in total described DS operations using varied terminology, including “tangential sleeve resection with circumferential anastomosis, extended sleeve resection, sleeve resection with pulmonary angioplasty, complex sleeve resections”, and most commonly “DS”. Of these 36 studies, 12 (n=233) described DS resections exclusively, while the rest discussed both single and DS resections. Our review found that current literature reports little difference in long-term overall survival (OS) between single and DS operations. Surgical approach (particularly thoracotomy vs. VATS) does not appear to be a determinant of survival in DS operations. Thoracoscopic techniques may offer shorter postoperative hospital stays and less postoperative pain. In experienced units, the oncological outcomes of DS are at least equivalent to single sleeve resections and pneumonectomy, with preservation of more lung and less postoperative complications. Conclusions: Thoracotomy remains the most used approach in DS lobectomies; VATS may offer shorter post-operative stays than the thoracotomy approach. RATS is currently too infrequently performed to make overarching conclusions, but short-term perioperative outcomes in single-centre reports are promising. We hope that this review provides a novel and comprehensive review of evolving trends in current surgical practices of DS operations to assist clinical decision making for maximum patient benefit.

Verified
Journal Article
Open access
PDF file
FNFatemeh Habibi Nameghi
Fatemeh Habibi Nameghi
JAJason Ali
Jason Ali
Minimal access cardiac surgery (MACS) can mitigate the increasing risk profile of cardiac surgery patients and is associated with improved postoperative outcomes. One of the ways to manage the steep learning curve of MACS is the use of surgical simulation training. We conducted a narrative review to identify the relevant literature discussing MACS simulation training. We identified 20 studies using our search strategy. Various platforms were represented: high-fidelity (n = 8), low-fidelity (n = 6), and animal studies (n = 6). Virtual reality (VR) appeared in two wet-lab studies as an adjunct. The surgical approach was video-assisted thoracoscopic surgery (VATS) in 11 and robotic-assisted thoracoscopic surgery (RATS) in nine. The most simulated procedure was minimal access mitral valve (MV) repair (n = 16). Most studies (n = 16) evaluated the impact of simulation training on the surgical skill of participants with varying baseline MACS experience. A small proportion of included studies (n = 4) carried out only fidelity testing. While some standardised assessment tools were used, there was considerable variation in how surgical skill and fidelity were assessed. There are an increasing number of publications on MACS simulation training, with equal focus on bench and animal models. MV procedures were the most simulated, suggesting a drive towards increasing the scope of minimal access MV training.